Comparative assessment of skeletal uptake on Ga-68 PSMA PET/CT versus F-18 Fluoride PET/CT in metastatic prostate cancer

被引:0
|
作者
Singh, Aviral [1 ]
Kulkarni, Harshad [1 ]
Niepsch, Karin [1 ]
Baum, Richard [1 ]
机构
[1] Zentralklin Bad Berka, THERANOST Ctr Mol Radiotherapy & Mol Imaging PET, Bad Berka, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1543
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall
    Soydal, Cigdem
    Demir, Burak
    Sutcu, Gizem
    Araz, Mine
    Kucuk, Nuriye Ozlem
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 150 - 152
  • [32] 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
    Bluemel, Christina
    Krebs, Markus
    Polat, Buelent
    Linke, Fraenze
    Eiber, Matthias
    Samnick, Samuel
    Lapa, Constantin
    Lassmann, Michael
    Riedmiller, Hubertus
    Czernin, Johannes
    Rubello, Domenico
    Bley, Thorsten
    Kropf, Saskia
    Wester, Hans-Juergen
    Buck, Andreas K.
    Herrmann, Ken
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 515 - 521
  • [33] Ga-68 PSMA PET/CT in metastatic or locally recurrent prostate cancer: Comparison to bone scan, CTor MRI
    Acar, E.
    Bekis, R.
    Ozdogan, O.
    Polack, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S345 - S345
  • [34] The Value of 68Ga-PSMA PET/CT Following Equivocal 18F-NaF PET/CT in Prostate Cancer Patients
    Madsen, Claus
    Ostergren, Peter
    Haarmark, Christian
    DIAGNOSTICS, 2020, 10 (06)
  • [35] Ga-68 labelled PSMA ligand based PET/CT scan for the detection of recurrence in prostate cancer patient and comparison with F-18 choline-based PET/CT scan in a tertiary care center
    Mittal, B. R.
    Shukla, J.
    Parghane, R. V.
    Phulsunga, R. K.
    Vatsa, R.
    Bhusari, P.
    Rana, N.
    Sood, A.
    Bhattacharya, A.
    Singh, S. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S384 - S385
  • [36] Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT
    Sertac Asa
    Kerim Sonmezoglu
    Lebriz Uslu-Besli
    Onur Erdem Sahin
    Emre Karayel
    Huseyin Pehlivanoglu
    Sait Sager
    Levent Kabasakal
    Meltem Ocak
    Haluk B. Sayman
    Annals of Nuclear Medicine, 2021, 35 : 900 - 915
  • [37] Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT
    Asa, Sertac
    Sonmezoglu, Kerim
    Uslu-Besli, Lebriz
    Sahin, Onur Erdem
    Karayel, Emre
    Pehlivanoglu, Huseyin
    Sager, Sait
    Kabasakal, Levent
    Ocak, Meltem
    Sayman, Haluk B.
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (08) : 900 - 915
  • [38] 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
    Gundogan, Cihan
    Ergul, Nurhan
    Cakir, Mehmet Semih
    Kilickesmez, Ozgur
    Gursu, Riza Umar
    Aksoy, Tamer
    Cermik, Tevfik Fikret
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 79 - 85
  • [39] F-18 Fluor Choline PET/CT vs F-18 Fluoride PET/CT in the detection of bone metastases in patients with prostate cancer
    Beheshti, M.
    Fitz, F.
    Haim, S.
    Nader, M.
    Poecher, S.
    Jordanova, N.
    Stoiber, F.
    Loidl, W.
    Langsteger, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S208 - S209
  • [40] 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer
    Tatar, Gamze
    Ergul, Nurhan
    Baloglu, Mehmet Can
    Arslan, Esra
    Cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : E135 - E137